Breast Neoplasms Clinical Trials in Québec, Quebec
4 recruitingQuébec, Quebec, Canada
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Breast Neoplasms
Merck Sharp & Dohme LLC1,200 enrolled257 locationsNCT06312176
Recruiting
Phase 3
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast NeoplasmsTriple Negative Breast NeoplasmsHR Low-Positive/HER2-Negative Breast Neoplasms
Merck Sharp & Dohme LLC2,400 enrolled234 locationsNCT06966700
Recruiting
Not Applicable
Angiomammography and Neoadjuvant Chemotherapy
Breast Neoplasms
CHU de Quebec-Universite Laval100 enrolled1 locationNCT05402930
Recruiting
Not Applicable
Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors
Breast CancerBreast Neoplasms
CHU de Quebec-Universite Laval66 enrolled1 locationNCT05887102